Wayne Koberstein

  1. Meeting Business Challenges By Design, Not Accident
    8/1/2019

    The story of the business challenges faced by Diasome Pharmaceuticals as it develops its insulin-enhancing delivery technology, which seeks to correct a long-known deficiency in subcutaneous injection of insulin.

  2. Companies To Watch: Bioharmony Therapeutics
    8/1/2019

    Bioharmony Therapeutics is developing novel, “lysin-based” antimicrobials. The company is out to change the world of antibiotics, not by tweaking an old formula, but by advancing an entirely new mode of action.

  3. Companies To Watch: Angion
    7/1/2019

    Angion is developing a small molecule mimetic of the hepatocyte growth factor (HGF), which works to protect kidney and other organ cells from damage due to disease, physical injury, and indirect consequences of surgery and trauma.

  4. Companies To Watch: Synlogic
    5/31/2019

    Synlogic is an early-stage developer of “synthetic biotic” medicines — therapeutics consisting of beneficial microbes genetically engineered to treat rare metabolic diseases.

  5. GlycoMimetics Aiming At Tough Targets
    5/1/2019

    An exclusive interview with Rachel King, a business person dedicated to a science-driven sector, who is CEO of GlycoMimetics, an oncology-focused biotechnology company.

  6. Companies To Watch: Provention Bio
    5/1/2019

    This 15-person virtual biotech is trying to stop immune-mediated disease early, before it becomes a chronic condition.

  7. Medicines360 On A Mission For Women
    5/1/2019

    Medicines360 is using all its developed-world revenue to extend access to essential medicines to all women, regardless of the economic and healthcare circumstances in their part of the world.

  8. Companies To Watch: Vyome Therapeutics
    4/1/2019

    Vyome Therapeutics has built platforms and is developing products that address antibiotic resistance in severe skin conditions.

  9. Garo Armen And Audacity At Agenus
    4/1/2019

    Garo Armen, CEO of Agenus and a long-time pharma industry veteran, has shown the instincts for simple money-making on one hand and the humanitarian side of biopharma on the other.

  10. Companies To Watch: Azitra
    3/1/2019

    Azitra is a small, young, early-stage company developing microbial biotherapeutics for conditions arising on the skin that can be addressed by using the microbiome.